Schedule 13D ownership disclosure
JOUNCE THERAPEUTICS INC
Security class unavailable · CUSIP: 481116101
Event date: 2023-03-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-23-003941
- Form type
- SC 13D
- Filer
- Jounce Therapeutics, Inc.
- CIK
- CIK 1640455
- Filed
- Mar 17, 2023
- Reporting period
- Mar 17, 2023
- Description
- Schedule 13D beneficial ownership